These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 24867309)
1. Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase. Liu Y; Duan D; Yao J; Zhang B; Peng S; Ma H; Song Y; Fang J J Med Chem; 2014 Jun; 57(12):5203-11. PubMed ID: 24867309 [TBL] [Abstract][Full Text] [Related]
2. Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis. Fan XY; Liu YJ; Chen K; Jiang FL; Hu YJ; Liu D; Liu Y; Ge YS Eur J Med Chem; 2018 Jan; 143():1090-1102. PubMed ID: 29150332 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent. Zhang J; Liu Y; Shi D; Hu G; Zhang B; Li X; Liu R; Han X; Yao X; Fang J Eur J Med Chem; 2017 Nov; 140():435-447. PubMed ID: 28987605 [TBL] [Abstract][Full Text] [Related]
4. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase. Zhang J; Yao J; Peng S; Li X; Fang J Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067 [TBL] [Abstract][Full Text] [Related]
5. Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment Song ZL; Zhang J; Xu Q; Shi D; Yao X; Fang J J Med Chem; 2021 Nov; 64(21):16132-16146. PubMed ID: 34704769 [TBL] [Abstract][Full Text] [Related]
7. Xanthatin Promotes Apoptosis via Inhibiting Thioredoxin Reductase and Eliciting Oxidative Stress. Liu R; Shi D; Zhang J; Li X; Han X; Yao X; Fang J Mol Pharm; 2018 Aug; 15(8):3285-3296. PubMed ID: 29939757 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells. Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J Biochem Pharmacol; 2016 Feb; 102():34-44. PubMed ID: 26686580 [TBL] [Abstract][Full Text] [Related]
9. Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis Duan D; Feng X; Pan D; Wang L; Wang Y; Wang X Curr Pharm Biotechnol; 2022; 23(14):1647-1657. PubMed ID: 34923938 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity. Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278 [TBL] [Abstract][Full Text] [Related]
11. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Duan D; Zhang B; Yao J; Liu Y; Fang J Free Radic Biol Med; 2014 May; 70():182-93. PubMed ID: 24583460 [TBL] [Abstract][Full Text] [Related]
12. Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells. Zhang J; Peng S; Li X; Liu R; Han X; Fang J Arch Biochem Biophys; 2017 Apr; 619():16-26. PubMed ID: 28249720 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302. Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent. Zhang B; Duan D; Ge C; Yao J; Liu Y; Li X; Fang J J Med Chem; 2015 Feb; 58(4):1795-805. PubMed ID: 25629304 [TBL] [Abstract][Full Text] [Related]
15. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Lu J; Chew EH; Holmgren A Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917 [TBL] [Abstract][Full Text] [Related]
16. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452 [TBL] [Abstract][Full Text] [Related]
17. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis. Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187 [TBL] [Abstract][Full Text] [Related]
19. On the potential of thioredoxin reductase inhibitors for cancer therapy. Urig S; Becker K Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271 [TBL] [Abstract][Full Text] [Related]
20. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage. Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]